UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Toward hepatitis C virus elimination using artificial intelligence

Clinical and molecular hepatology, 2024-04, Vol.30 (2), p.147

2024

Volltextzugriff (PDF)

Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019

Clinical infectious diseases, 2020-11, Vol.71 (16), p.2294-2297

2020

Volltextzugriff (PDF)

Two Cases of Hepatocellular Carcinoma Arising Over 20 years After a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C

Internal Medicine, 2020, pp.4479-20

2020

Volltextzugriff (PDF)

Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis

Gastroenterology (New York, N.Y. 1943), 2017-11, Vol.153 (5), p.1273-1283.e1

2017

Volltextzugriff (PDF)

Reversion of disease manifestations after HCV eradication

Journal of hepatology, 2016-10, Vol.65 (1), p.S95-S108

2016

Volltextzugriff (PDF)

Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication

Journal of hepatology, 2017-03, Vol.66 (3), p.485-493

2017

Volltextzugriff (PDF)

Real-world Safety and Effectiveness of 24-week Sofosbuvir and Ribavirin Treatment in Patients Infected with Rare Chronic Hepatitis C Virus Genotypes 3, 4, 5, or 6 in Japan

Internal Medicine, 2022, pp.0067-22

2022

Volltextzugriff (PDF)

Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.1683-1692.e1

2019

Volltextzugriff (PDF)

Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis

Clinical gastroenterology and hepatology, 2018-01, Vol.16 (1), p.27-38.e4

2018

Volltextzugriff (PDF)

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase

Blood, 2017-04, Vol.129 (17), p.2437-2442

2017

Volltextzugriff (PDF)

The short‐term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct‐acting antivirals: An ERCHIVES study

Hepatology (Baltimore, Md.), 2018-06, Vol.67 (6), p.2244-2253

2018

Volltextzugriff (PDF)

Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease

Gastroenterology (New York, N.Y. 1943), 2016-06, Vol.150 (7), p.1590-1598

2016

Volltextzugriff (PDF)

Hepatitis C Virus NAT‐Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus–Negative Recipients: A Real‐World Experience

Hepatology (Baltimore, Md.), 2020-07, Vol.72 (1), p.32-41

2020

Volltextzugriff (PDF)

High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis

Journal of hepatology, 2018-08, Vol.69 (2), p.293-300

2018

Volltextzugriff (PDF)

Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data

Journal of acquired immune deficiency syndromes (1999), 2019-11, Vol.82 (3), p.245-251

2019

Volltextzugriff (PDF)

Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir

Gastroenterology (New York, N.Y. 1943), 2016-09, Vol.151 (3), p.501-512.e1

2016

Volltextzugriff (PDF)

Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response

Clinical infectious diseases, 2015-09, Vol.61 (5), p.730-740

2015

Volltextzugriff (PDF)

Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs

Annals of hepatology, 2024-09, p.101582, Article 101582

2024

Volltextzugriff (PDF)

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

The lancet HIV, 2019-04, Vol.6 (4), p.e259-e268

2019

Volltextzugriff (PDF)

Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals

Cell host & microbe, 2016-09, Vol.20 (3), p.368-380

2016

Volltextzugriff (PDF)

Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy

Gastroenterology (New York, N.Y. 1943), 2019-03, Vol.156 (4), p.997-1009.e5

2019

Volltextzugriff (PDF)

Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C

Hepatology (Baltimore, Md.), 2018-05, Vol.67 (5), p.1683-1694

2018

Volltextzugriff (PDF)

Treatment of hepatitis C virus infection with direct‐acting antiviral agents: 100% cure?

Liver international, 2018-02, Vol.38 (S1), p.7-13

2018

Volltextzugriff (PDF)

26 – 50 von 2.204

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.046)
Mit Volltextzugriff
(1.897)

Publikationsform

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Sustained Virologic Response
(2.170)
Science & Technology
(1.920)
Life Sciences & Biomedicine
(1.862)
Humans
(1.836)
Male
(1.324)
Female
(1.293)
Middle Aged
(1.174)
Antiviral Agents - Therapeutic Use
(1.161)
Hepatitis C, Chronic - Drug Therapy
(1.091)
Hepatitis C
(972)
Gastroenterology & Hepatology
(921)
Adult
(911)
Aged
(692)
Treatment Outcome
(681)
Hepacivirus - Genetics
(621)
Hepatitis C Virus
(592)
Hepatitis
(590)
Genotype
(562)
Infectious Diseases
(552)
Drug Therapy, Combination
(548)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Toward hepatitis C virus elimination using artificial intelligence

Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019

Two Cases of Hepatocellular Carcinoma Arising Over 20 years After a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C

Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis

HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response

Reversion of disease manifestations after HCV eradication

Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication

HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease

Real-world Safety and Effectiveness of 24-week Sofosbuvir and Ribavirin Treatment in Patients Infected with Rare Chronic Hepatitis C Virus Genotypes 3, 4, 5, or 6 in Japan

Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study

Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase

The short‐term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct‐acting antivirals: An ERCHIVES study

Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease

Hepatitis C Virus NAT‐Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus–Negative Recipients: A Real‐World Experience

High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis

Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data

Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir

Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response

Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals

Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy

Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C

Treatment of hepatitis C virus infection with direct‐acting antiviral agents: 100% cure?

Suchergebnisse filtern